A research team at the Icahn School of Medicine at Mount Sinai, New York has won the 2022…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
CENTOGENE has announced it’s reached a milestone of 12,500 participants who have been recruited and genetically tested as part…
Older age at onset, more severe motor symptoms, and cognitive impairment are risk factors for the progression of gait and…
Free art therapy workshops for Parkinson’s disease patients and their caregivers will take place this fall in Little Rock…
Poor sleep quality is a key factor in developing dyskinesia, the uncontrolled and involuntary movements that can affect people with …
Researchers have devised a new method to generate dopamine-producing neurons from skin cells of Parkinson’s disease patients, a process…
Servier is set to launch a Phase 1 clinical trial in healthy volunteers to investigate an LRRK2 inhibitor, developed in…
Older age at onset, a faster rate of disease progression, and severe cognitive impairment are key factors in poorer survival…
Continuously monitoring the gait of Parkinson’s disease patients in their homes using a wireless device is feasible and may…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced it will expand the number and reach of…